Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting

Kevin C. Oeffinger, Debra A. Eshelman, Gail E. Tomlinson, George R. Buchanan, Barbara M. Foster

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

BACKGROUND. The objective of the current study was to describe a multidisciplinary transition program for following young adult survivors of childhood cancer in an adult-based ambulatory medical setting and to report the late effects with grades of toxicity diagnosed in all adult survivors followed in the program. METHODS. The study population was comprised of all young adult survivors (n = 96) of childhood cancer who were seen in the After the Cancer Experience (ACE) Young Adult Program prior to January 31, 1999. The median age of the survivors was 22.8 years (range, 17-34 years) and the median interval from the time of cancer diagnosis was 15.2 years (range, 6-25 years). Primary cancer groups included: leukemia, 33%; sarcoma, 24%; Hodgkin disease, 15%; non-Hodgkin lymphoma, 12%; Wilms' tumor, 9%; and other, 7%. Late effects were graded using the Common Toxicity Criteria, Version 2 (CTCv2), developed by the National Cancer Institute. RESULTS. Approximately 69% of the patients (66 of 96) had at least 1 late effect. Thirty-three percent of patients had a single late effect whereas 36% had ≥ 2 late effects. Thirty percent of patients had a CTCv2 Grade 3 or 4 late effect. CONCLUSIONS. The current study represents an example of a successful multidisciplinary transition program in an ambulatory, adult setting for young adult survivors of childhood cancer. Late effects of cancer treatment are common in young adult survivors, with approximately 33% being moderate to severe. Further studies are needed to modify CTCv2-with the aim of developing a reliable and valid tool to assess late effects in long term survivors of childhood cancer. (C) 2000 American Cancer Society.

Original languageEnglish (US)
Pages (from-to)1687-1695
Number of pages9
JournalCancer
Volume88
Issue number7
DOIs
StatePublished - Apr 1 2000

Fingerprint

Survivors
Young Adult
Neoplasms
Wilms Tumor
National Cancer Institute (U.S.)
Hodgkin Disease
Sarcoma
Non-Hodgkin's Lymphoma
Leukemia
Population

Keywords

  • Adolescence
  • Child
  • Common Toxicity Criteria
  • Follow-up studies
  • Late effects
  • Neoplasm
  • Survivors
  • Transition
  • Young adult

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. / Oeffinger, Kevin C.; Eshelman, Debra A.; Tomlinson, Gail E.; Buchanan, George R.; Foster, Barbara M.

In: Cancer, Vol. 88, No. 7, 01.04.2000, p. 1687-1695.

Research output: Contribution to journalArticle

Oeffinger, Kevin C. ; Eshelman, Debra A. ; Tomlinson, Gail E. ; Buchanan, George R. ; Foster, Barbara M. / Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. In: Cancer. 2000 ; Vol. 88, No. 7. pp. 1687-1695.
@article{51d05e9b38234beb8d3f362b5ede6a1a,
title = "Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting",
abstract = "BACKGROUND. The objective of the current study was to describe a multidisciplinary transition program for following young adult survivors of childhood cancer in an adult-based ambulatory medical setting and to report the late effects with grades of toxicity diagnosed in all adult survivors followed in the program. METHODS. The study population was comprised of all young adult survivors (n = 96) of childhood cancer who were seen in the After the Cancer Experience (ACE) Young Adult Program prior to January 31, 1999. The median age of the survivors was 22.8 years (range, 17-34 years) and the median interval from the time of cancer diagnosis was 15.2 years (range, 6-25 years). Primary cancer groups included: leukemia, 33{\%}; sarcoma, 24{\%}; Hodgkin disease, 15{\%}; non-Hodgkin lymphoma, 12{\%}; Wilms' tumor, 9{\%}; and other, 7{\%}. Late effects were graded using the Common Toxicity Criteria, Version 2 (CTCv2), developed by the National Cancer Institute. RESULTS. Approximately 69{\%} of the patients (66 of 96) had at least 1 late effect. Thirty-three percent of patients had a single late effect whereas 36{\%} had ≥ 2 late effects. Thirty percent of patients had a CTCv2 Grade 3 or 4 late effect. CONCLUSIONS. The current study represents an example of a successful multidisciplinary transition program in an ambulatory, adult setting for young adult survivors of childhood cancer. Late effects of cancer treatment are common in young adult survivors, with approximately 33{\%} being moderate to severe. Further studies are needed to modify CTCv2-with the aim of developing a reliable and valid tool to assess late effects in long term survivors of childhood cancer. (C) 2000 American Cancer Society.",
keywords = "Adolescence, Child, Common Toxicity Criteria, Follow-up studies, Late effects, Neoplasm, Survivors, Transition, Young adult",
author = "Oeffinger, {Kevin C.} and Eshelman, {Debra A.} and Tomlinson, {Gail E.} and Buchanan, {George R.} and Foster, {Barbara M.}",
year = "2000",
month = "4",
day = "1",
doi = "10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M",
language = "English (US)",
volume = "88",
pages = "1687--1695",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting

AU - Oeffinger, Kevin C.

AU - Eshelman, Debra A.

AU - Tomlinson, Gail E.

AU - Buchanan, George R.

AU - Foster, Barbara M.

PY - 2000/4/1

Y1 - 2000/4/1

N2 - BACKGROUND. The objective of the current study was to describe a multidisciplinary transition program for following young adult survivors of childhood cancer in an adult-based ambulatory medical setting and to report the late effects with grades of toxicity diagnosed in all adult survivors followed in the program. METHODS. The study population was comprised of all young adult survivors (n = 96) of childhood cancer who were seen in the After the Cancer Experience (ACE) Young Adult Program prior to January 31, 1999. The median age of the survivors was 22.8 years (range, 17-34 years) and the median interval from the time of cancer diagnosis was 15.2 years (range, 6-25 years). Primary cancer groups included: leukemia, 33%; sarcoma, 24%; Hodgkin disease, 15%; non-Hodgkin lymphoma, 12%; Wilms' tumor, 9%; and other, 7%. Late effects were graded using the Common Toxicity Criteria, Version 2 (CTCv2), developed by the National Cancer Institute. RESULTS. Approximately 69% of the patients (66 of 96) had at least 1 late effect. Thirty-three percent of patients had a single late effect whereas 36% had ≥ 2 late effects. Thirty percent of patients had a CTCv2 Grade 3 or 4 late effect. CONCLUSIONS. The current study represents an example of a successful multidisciplinary transition program in an ambulatory, adult setting for young adult survivors of childhood cancer. Late effects of cancer treatment are common in young adult survivors, with approximately 33% being moderate to severe. Further studies are needed to modify CTCv2-with the aim of developing a reliable and valid tool to assess late effects in long term survivors of childhood cancer. (C) 2000 American Cancer Society.

AB - BACKGROUND. The objective of the current study was to describe a multidisciplinary transition program for following young adult survivors of childhood cancer in an adult-based ambulatory medical setting and to report the late effects with grades of toxicity diagnosed in all adult survivors followed in the program. METHODS. The study population was comprised of all young adult survivors (n = 96) of childhood cancer who were seen in the After the Cancer Experience (ACE) Young Adult Program prior to January 31, 1999. The median age of the survivors was 22.8 years (range, 17-34 years) and the median interval from the time of cancer diagnosis was 15.2 years (range, 6-25 years). Primary cancer groups included: leukemia, 33%; sarcoma, 24%; Hodgkin disease, 15%; non-Hodgkin lymphoma, 12%; Wilms' tumor, 9%; and other, 7%. Late effects were graded using the Common Toxicity Criteria, Version 2 (CTCv2), developed by the National Cancer Institute. RESULTS. Approximately 69% of the patients (66 of 96) had at least 1 late effect. Thirty-three percent of patients had a single late effect whereas 36% had ≥ 2 late effects. Thirty percent of patients had a CTCv2 Grade 3 or 4 late effect. CONCLUSIONS. The current study represents an example of a successful multidisciplinary transition program in an ambulatory, adult setting for young adult survivors of childhood cancer. Late effects of cancer treatment are common in young adult survivors, with approximately 33% being moderate to severe. Further studies are needed to modify CTCv2-with the aim of developing a reliable and valid tool to assess late effects in long term survivors of childhood cancer. (C) 2000 American Cancer Society.

KW - Adolescence

KW - Child

KW - Common Toxicity Criteria

KW - Follow-up studies

KW - Late effects

KW - Neoplasm

KW - Survivors

KW - Transition

KW - Young adult

UR - http://www.scopus.com/inward/record.url?scp=0034177225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034177225&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M

DO - 10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M

M3 - Article

C2 - 10738228

AN - SCOPUS:0034177225

VL - 88

SP - 1687

EP - 1695

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -